Angiotensin II Captopril Cotreatment Augments Angiogenesis in Abdominal Skin Flap in Rats
Authors:
- Hale TufanHTHale Tufan
- Basim M. ZakiBZBasim M. Zaki
- Müge Tecder-ÜnalMTMüge Tecder-Ünal
- Ş Remzi ErdemŞEŞ Remzi Erdem
- Gülnur TakeGTGülnur Take
- 1 April 2007
- journal article
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 58 (4) , 441-448
Abstract
The effect of captopril, angiotensin-converting enzyme inhibitor, on angiogenesis in several reports remained unclear. Its effect on neovascularization in rat abdominal skin flaps was investigated. Flap elevation, based on the right superficial inferior epigastric artery was performed with or without the administration of captopril (10 mg/kg/d), Ang II (100 microg/kg/d), or captopril and Ang II cotreatment. Mean arterial pressure (MAP), microangiography, capillary density measurement, necrosis area determination, laser Doppler flowmetry (LDF), AT1 and vascular endothelial growth factor (VEGF) immunostaining were used to evaluate the effects of captopril and the interaction between captopril and Ang II on the angiogenesis. Ang II and captopril cotreatment improved angiogenesis more than Ang II or captopril alone. The reduction of necrosis, enhancement of vascular network formation, capillary density, VEGF immunostaining, and local blood flow were evident in the cotreated group. We suggest that Ang II and captopril cotreatment improves ischemia-induced angiogenesis and increased viability and vascularity of skin flap in rats.Keywords
This publication has 38 references indexed in Scilit:
- Angiotensin converting enzyme inhibitors for cancer treatment?Acta Oncologica, 2004
- Endothelial Nitric Oxide Synthase Lies Downstream From Angiotensin II–Induced Angiogenesis in Ischemic HindlimbHypertension, 2002
- Angiotensin AT 1 and AT 2 Receptors Differentially Regulate Angiopoietin-2 and Vascular Endothelial Growth Factor Expression and Angiogenesis by Modulating Heparin Binding–Epidermal Growth Factor (EGF)–Mediated EGF Receptor TransactivationCirculation Research, 2001
- Opposing actions of angiotensins on angiogenesisLife Sciences, 1999
- Effects of angiotensin II on endothelial cell growthJournal of the American Society of Nephrology, 1998
- Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granulomaBritish Journal of Pharmacology, 1997
- Angiotensin-(1-7) Inhibits Vascular Smooth Muscle Cell GrowthHypertension, 1996
- Opposing Actions of Angiotensin II on Microvascular Growth and Arterial Blood PressureHypertension, 1996
- Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins‐1 and −3 and angiotensin II in a rat sponge modelBritish Journal of Pharmacology, 1996
- Changes in skin angiotensin II receptors in rats during wound healingBiochemical and Biophysical Research Communications, 1992